计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
Moligand™ 级 提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 2 篇同行评审文献引用。
Gestodene(SHB 331;WL 70) is a progestogen hormonal contraceptive. Target: Estrogen Receptor/ERR Gestodene is androgenically neutral, meaning that contraceptive pills containing gestodene do not exhibit the androgenic side effects (e.g. acne, hirsutism, weight gain) often associated with second-generation contraceptive pills, such as those containing levonorgestrel. When 40 micrograms of gestodene was taken, six out of seven women did not ovulate, and one out of seven had a cycle with luteal insufficiency. These data indicate that 40 micrograms of gestodene is the borderline dose for inhibition of ovulation. A combination of 75 micrograms gestodene with 30 micrograms ethinyl estradiol was found to inhibit ovulation in ten subjects, and no follicular maturation was noted . gestodene bound with high affinity to the progesterone receptor, as did other synthetic and natural progestogens. However, gestodene did not bind to the estradiol receptor. The relative binding affinities of all tested synthetic and natural ligands showed no organ-specific differences and no differences between neoplastically transformed and normal tissues . Clinical indications: Female contraception
Gestodene(SHB 331;WL 70) is a progestogen hormonal contraceptive. Target: Estrogen Receptor/ERR Gestodene is androgenically neutral, meaning that contraceptive pills containing gestodene do not exhibit the androgenic side effects (e.g. acne, hirsutism, weight gain) often associated with second-generation contraceptive pills, such as those containing levonorgestrel. When 40 micrograms of gestodene was taken, six out of seven women did not ovulate, and one out of seven had a cycle with luteal insufficiency. These data indicate that 40 micrograms of gestodene is the borderline dose for inhibition of ovulation. A combination of 75 micrograms gestodene with 30 micrograms ethinyl estradiol was found to inhibit ovulation in ten subjects, and no follicular maturation was noted . gestodene bound with high affinity to the progesterone receptor, as did other synthetic and natural progestogens. However, gestodene did not bind to the estradiol receptor. The relative binding affinities of all tested synthetic and natural ligands showed no organ-specific differences and no differences between neoplastically transformed and normal tissues . Clinical indications: Female contraception
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 脂质和脂质样分子 |
| 类(Class) | 类固醇和类固醇衍生物 |
| 亚类(Subclass) | 雌烷类固醇 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 雌激素及其衍生物 |
| 其他上位类(Alternative Parents) | 3-氧代类固醇 17-羟基类固醇 环己酮 伊诺内斯 叔醇 乙炔化物 有机氧化物 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 脂肪族同多环化合物 |
| 取代基(Substituents) | 17-羟基类固醇 - 3-氧代-1,4-甾体 - 乙炔 - 羟基苯甲酸酯 - 脂肪族同多环化合物 - 羰基 - 环酮 - 环己烯酮 - 雌激素骨架 - 烃衍生物 - 羟基吡啶 - 酮 - 有机氧化物 - 有机氧化合物 - 有机氧化合物 - 氧甾类 - 三烷基醇 - Ynone |
| 描述(Description) | 该化合物属于雌激素及其衍生物类有机化合物。这类类固醇具有含3-羟基雌烷的结构。 |
| 外部描述符(External Descriptors) | 暂无 |
| ALogP | 2.9 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
H351: 怀疑引起遗传缺陷
H360: 可能损害生育力或未出生的孩子
H361: 怀疑破坏生育力或未出生的孩子
H362: 可能对母乳喂养的孩子造成伤害
H400: 对水生生物有剧毒
H410: 对水生生物有剧毒并具有长期持续影响
P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。
P263: 避免在怀孕期间/哺乳期间接触。
P264: 处理后要彻底洗手。
P270: 使用本产品时,请勿进食、饮水或吸烟。
P273: 避免释放到环境中。
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。
P391: 收集溢出物
P405: 密闭存放
P501: 将内容物/容器处理到。。。
P203: 使用前,获取、阅读并遵守所有安全说明。
P318: 如果暴露或担心,请就医。